Astrocytoma, IDH-Mutant, Grade 2

specific

IDH-mutant astrocytoma characterized by the presence of necrosis and/or microvascular proliferation or homozygous deletion of CDKN2A and/or CDKN2B genes. The term glioblastoma no longer applies to central nervous system WHO grade 4 IDH-mutant astrocytomas. (WHO 2021)

37

Centers

46

Active Trials

Cancer Funding

Top Centers for Astrocytoma, IDH-Mutant, Grade 2(37)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.2
2
NCI Comprehensive
Active Research Program
68.4
3
NCI Comprehensive
Active Research Program
68.4
4
NCI Comprehensive
Active Research Program
68.4
5
NCI Comprehensive
Active Research Program
68.4
6
NCI Comprehensive
Active Research Program
68.4
7
NCI Clinical
Active Research Program
68.4
8
Active Research Program
68.4
9
NCI Comprehensive
Active Research Program
46.5
10
NCI Comprehensive
Active Research Program
46.5
11
NCI Comprehensive
Active Research Program
46.5
12
NCI Comprehensive
Active Research Program
46.5
13
NCI Comprehensive
Active Research Program
46.5
14
NCI Comprehensive
Active Research Program
46.5
15
NCI Comprehensive
Active Research Program
46.5
16
NCI Comprehensive
Active Research Program
46.5
17
NCI Comprehensive
Active Research Program
46.5
18
NCI Comprehensive
Active Research Program
46.5
19
NCI Comprehensive
Active Research Program
46.5
2046.5
21
NCI Comprehensive
Active Research Program
46.5
22
NCI Comprehensive
Active Research Program
46.5
23
NCI Comprehensive
Active Research Program
46.5
24
NCI Comprehensive
Active Research Program
46.5
25
NCI Comprehensive
Active Research Program
46.5
26
NCI Comprehensive
Active Research Program
46.5
27
NCI Comprehensive
Active Research Program
46.5
28
Active Research Program
46.5
29
NCI Comprehensive
Active Research Program
46.5
30
Active Research Program
46.5
31
NCI Comprehensive
Active Research Program
46.5
32
NCI Comprehensive
Active Research Program
46.5
33
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
46.5
34
Active Research Program
46.5
35
Active Research Program
46.5
36
Active Research Program
46.5
37
Active Research Program
46.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →